ARGX · argenx SE American Depositary Shares

ARGX argenx SE American Depositary Shares

Sonstige · Unbekannt · ← Sonstige Index

Gesamt ×39RS-Rating 69vom Hoch -5%Ø $-Vol 256MMax-Runup ×54Max-DD -40%ADR 2.8%Score 557Setups 10Rallyes 6Earnings 25Surf 100%🏄 10/20-Surfer

▲ im Chart anklicken → springt zur Zeile

Grade	Base-Start	Breakout	Tage	Tiefe%	Vorlauf%	Δ Tag%	Gap%	Vol×	Dry-Up%	ADR%	ext10%	Surf%	Setup	Formation	Katalysator
B	2017-11-30	2017-12-11	7	20.6	+74	+78.9	36.6	16.6	-163	6.1	69	71	Episodic Pivot (Gap)	Flag / Pennant	—:
C	2018-11-06	2018-12-03	18	19.5	+61	+13.5	8.9	4.3	14	3.9	17	78	Episodic Pivot (Gap)	Flag / Pennant	—:
C	2019-12-17	2020-01-09	15	8.1	+57	+5.6	7.0	3.4	31	1.9	3	100	Episodic Pivot (Gap)	Flag / Pennant	—:
C	2021-01-25	2021-02-01	5	11.4	+29	+8.3	8.4	2.6	-2	3.2	5	40	Episodic Pivot (Gap)	Flag / Pennant	—:
C	2021-11-04	2021-12-20	31	20.5	+21	+8.8	8.7	4.3	-25	3.6	10	40	Episodic Pivot (Gap)	VCP (Contraction)	News: Is Argenx a Good Biotech Stock to Buy for 2022? ↗
C	2022-07-05	2022-07-28	17	10.0	+44	+4.2	8.2	1.9	-3	3.1	2	40	Episodic Pivot (Gap)	VCP (Contraction)	Earnings: Earnings-Report (SEC 8-K 2.02) ↗
C	2023-05-22	2023-07-17	37	13.2	+27	+27.8	26.0	11.9	22	2.1	24	40	Episodic Pivot (Gap)	Flat Base	News: Immunovant's FcRn Strategy Gains Momentum: Analysts View ADHERE Study as De-Risking Factor ↗
C	2024-05-08	2024-06-24	31	11.9	+15	+11.7	11.5	3.4	-12	2.5	13	40	Episodic Pivot (Gap)	Flat Base	News: argenx Highlights Breadth of Autoimmune Pipeline with New Multifocal Motor Neuropathy Data ↗
C	2024-10-23	2024-10-31	6	4.6	+20	+6.3	6.9	4.1	41	2.2	5	100	Episodic Pivot (Gap)	—	Earnings: Earnings-Report (SEC 8-K 2.02)
C	2025-05-05	2025-07-31	60	22.6	+27	+11.9	14.9	3.6	-22	2.1	13	40	Episodic Pivot (Gap)	—	Earnings: Earnings-Report (SEC 8-K 2.02)

Breakouts 10Trefferquote 50%Ø gehalten +14.8%Median +7.9%Ø Peak +28%Ø hergegeben −13%

Breakout	G	Entry	gehalten	Peak	hergeg.	Tage	Exit
2017-12-11	B	35.71	+114.6%	+143.6%	−29.0%	53	2018-02-28
2018-12-03	C	103	-7.3%	+8.2%	−15.4%	11	2018-12-19
2020-01-09	C	168	-6.5%	+1.1%	−7.6%	2	2020-01-13
2021-02-01	C	317	+9.0%	+20.5%	−11.5%	15	2021-02-23
2021-12-20	C	334	-6.3%	+7.0%	−13.3%	13	2022-01-07
2022-07-28	C	384	-7.5%	+1.1%	−8.6%	2	2022-08-01
2023-07-17	C	424	+15.2%	+29.9%	−14.7%	24	2023-08-18
2024-06-24	C	401	+30.4%	+38.5%	−8.1%	59	2024-09-17
2024-10-31	C	572	-1.4%	+6.9%	−8.2%	11	2024-11-15
2025-07-31	C	659	+7.9%	+18.2%	−10.3%	39	2025-09-25

Regel: Einstieg am Breakout-Pivot, Trailing-Stop = Tagesschluss unter dem 20-EMA. gehalten = realisierter Gewinn bis zum Stop · Peak = max. Run-Up (MFE) · hergeg. = Peak − gehalten · „offen" = Position läuft noch.

Jahr	Rendite	Spanne	Max-DD	Setups	Schluss
2017	+175%	300%	-15%	1	63.14
2018	+52%	101%	-36%	1	96.07
2019	+67%	74%	-29%		161
2020	+83%	201%	-34%	1	294
2021	+19%	54%	-32%	2	350
2022	+8%	63%	-28%	1	379
2023	+0%	68%	-38%	1	380
2024	+62%	84%	-14%	2	615
2025	+37%	83%	-21%	1	841
2026	+6%	35%	-23%		891

▲ 2017-06-26 → 2018-06-12 +407% (238 HT)

Auslöser: — (Momentum/sektorgetrieben)

▲ 2020-03-16 → 2021-02-11 +249% (230 HT)

Auslöser: — (Momentum/sektorgetrieben)

▲ 2023-12-20 → 2025-11-17 +174% (478 HT)

Auslöser: News: Why Argenx's (ARGX) Stock Price Moved Up 11% on Thursday

2024-03-21 +11% [News] Why Argenx's (ARGX) Stock Price Moved Up 11% on Thursday
2024-06-24 +12% [News] argenx Highlights Breadth of Autoimmune Pipeline with New Multifocal M
2024-10-31 +6% [Earnings] Earnings-Report (SEC 8-K 2.02)
2025-07-31 +12% [Earnings] Earnings-Report (SEC 8-K 2.02)

▲ 2018-10-10 → 2019-07-18 +136% (192 HT)

Auslöser: — (Momentum/sektorgetrieben)

▲ 2022-01-27 → 2023-07-21 +116% (371 HT)

Auslöser: News: argenx announces results of Annual General Meeting of Shareholders

2022-05-10 +11% [News] argenx announces results of Annual General Meeting of Shareholders
2022-07-28 +4% [Earnings] Earnings-Report (SEC 8-K 2.02)
2023-07-17 +28% [News] Immunovant's FcRn Strategy Gains Momentum: Analysts View ADHERE Study

▲ 2019-10-08 → 2020-01-09 +55% (64 HT)

Auslöser: — (Momentum/sektorgetrieben)